AIM
EVLO

ARK Investment Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

ARK Investment Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,834
Closed -$2.88M – 204
2018
Q3 		$2.88M Buy
11,834
+5,492
+87% +$1.44M 0.09% 85
2018
Q2 		$1.5M Buy
+6,342
New +$1.85M 0.05% 98

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

ARK Investment Management's EVLO Position: Q4 2018 in Review

ARK Investment Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2018, closing a stake of 11,834 shares — an estimated $2.88M sold.

ARK Investment Management first reported a position in EVLO in Q2 2018 and held it in 2 quarters. The position peaked at $2.88M in Q3 2018. 40 funds tracked by Wall St. Rank hold EVLO as of Q4 2018.

  • ARK Investment Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • ARK Investment Management sold 11,834 Evelo Biosciences, Inc. Common Stock shares in Q4 2018, an estimated $2.88M.
  • ARK Investment Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • ARK Investment Management's Evelo Biosciences, Inc. Common Stock position peaked at $2.88M in Q3 2018.
  • 40 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2018.

Based on ARK Investment Management's 13F filing for Q4 2018, filed 1 Feb 2019.